top of page

Free Biopharma Daily Stock Updates - 01/03/22

$XBI $115.44 +3.11% %

 

Covid Updates

$MRNA -7.5% Moderna Announces Supply Agreement with South Korea for Additional 20 Million Doses of Moderna’s COVID-19 Vaccine or Updated Booster Candidate in 2022 source


$PFE -4.1% & $BNTX -10.1% Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 12 Years of Age and Older. source


$AMRS +8.3% Amyris and Immunitybio Complete Joint Venture for Next Generation Covid-19 RNA Vaccine. source


$HGEN +4.0% Lenzilumab Treatment Response in Hospitalized COVID-19 Patients Correlates with C-Reactive Protein Levels. source


$NVAX -0.1% Novavax Submits Final Data Packages to U.S. FDA as Prerequisite to Emergency Use Authorization Application Request for COVID-19 Vaccine. source



Pipeline Updates

$JAZZ +2.8% U.S. FDA Grants Orphan Drug Exclusivity (ODE) for Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Idiopathic Hypersomnia in Adults source


$SPRO -5.4% Spero Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Tebipenem HBr for the Treatment of Complicated Urinary Tract Infections including Pyelonephritis. source


$PIRS +3.4% Pieris Pharmaceuticals Announces Successful Completion of Safety Milestone and Initiation of Efficacy Portion of Phase 2a Trial of PRS-060/AZD1402. source


$ANEB +3.9% Anebulo Pharmaceuticals Announces Initiation of Phase 2 Clinical Study Evaluating ANEB-001 for the Treatment of Acute Cannabinoid Intoxication. source



Business Updates

$CASI +5.7% CASI Pharmaceuticals Receives Nasdaq Deficiency Notice. source


 

Posted by FS/JM

0 comments

Comentarios


bottom of page